OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 122 filers reported holding OCULAR THERAPEUTIX INC in Q2 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $265,421 | -39.1% | 84,529 | 0.0% | 0.01% | -44.4% |
Q2 2023 | $436,170 | -2.1% | 84,529 | 0.0% | 0.01% | -10.0% |
Q1 2023 | $445,468 | +13.6% | 84,529 | -39.4% | 0.01% | -9.1% |
Q4 2022 | $392,076 | -66.7% | 139,529 | -50.9% | 0.01% | -65.6% |
Q3 2022 | $1,178,000 | +3.2% | 283,933 | 0.0% | 0.03% | -8.6% |
Q2 2022 | $1,141,000 | -43.5% | 283,933 | -30.4% | 0.04% | -27.1% |
Q1 2022 | $2,019,000 | -29.0% | 407,933 | 0.0% | 0.05% | -27.3% |
Q4 2021 | $2,843,000 | -54.8% | 407,933 | -35.1% | 0.07% | -60.5% |
Q3 2021 | $6,289,000 | -29.5% | 628,982 | +0.0% | 0.17% | -36.3% |
Q2 2021 | $8,918,000 | -13.6% | 628,933 | 0.0% | 0.26% | -38.5% |
Q1 2021 | $10,321,000 | -20.7% | 628,933 | 0.0% | 0.43% | -26.4% |
Q4 2020 | $13,019,000 | +151.9% | 628,933 | -7.4% | 0.58% | +108.3% |
Q3 2020 | $5,169,000 | -8.6% | 679,233 | 0.0% | 0.28% | -24.3% |
Q2 2020 | $5,658,000 | +346.6% | 679,233 | +165.3% | 0.37% | +259.8% |
Q1 2020 | $1,267,000 | +25.3% | 256,045 | 0.0% | 0.10% | +14.6% |
Q4 2019 | $1,011,000 | – | 256,045 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SUMMER ROAD LLC | 5,618,861 | $116,310,000 | 100.00% |
Opaleye Management Inc. | 6,510,000 | $134,758,000 | 17.60% |
DELTEC ASSET MANAGEMENT LLC | 2,168,573 | $44,889,000 | 6.87% |
Versant Venture Management, LLC | 1,465,384 | $30,333,000 | 3.15% |
GREAT POINT PARTNERS LLC | 856,162 | $17,723,000 | 2.88% |
Affinity Asset Advisors, LLC | 220,000 | $4,554,000 | 2.41% |
Altium Capital Management LP | 303,174 | $6,276,000 | 2.34% |
Endurant Capital Management LP | 290,465 | $6,013,000 | 2.17% |
MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 50,396 | $1,043,000 | 1.17% |
Lisanti Capital Growth, LLC | 366,040 | $7,577,000 | 1.05% |